Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2020 2
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management.
Miarons M, Larrosa-García M, García-García S, Los-Arcos I, Moreso F, Berastegui C, Castells L, Pérez-Hoyos S, Varela J, Pau-Parra A, Varón-Galcera C, Parramon-Teixidó CJ, Martínez-Casanova J, Domènech L, García-Ortega P, Sánchez-Sancho P, Alonso-Martínez C, Gómez-Ganda L, Roch-Santed M, Gracia-Moya A, Del-Rio-Gutiérrez JM, Guillén-Del-Castillo A, Sans-Pola C, Antón A, Montoro B, Gorgas-Torner MQ; Vall d’Hebron COVID-19 Working Group. Miarons M, et al. Among authors: larrosa garcia m. Transplantation. 2021 Jan 1;105(1):138-150. doi: 10.1097/TP.0000000000003460. Transplantation. 2021. PMID: 32941394
Tigecycline-associated hypofibrinogenemia in a real-world setting.
Campany-Herrero D, Larrosa-Garcia M, Lalueza-Broto P, Rivera-Sánchez L, Espinosa-Pereiro J, Mestre-Torres J, Pigrau-Serrallach C. Campany-Herrero D, et al. Among authors: larrosa garcia m. Int J Clin Pharm. 2020 Aug;42(4):1184-1189. doi: 10.1007/s11096-020-01072-7. Epub 2020 Jun 5. Int J Clin Pharm. 2020. PMID: 32504166
Case report: tolvaptan-associated creatine kinase elevation in two patients with autosomal dominant polycystic kidney disease (ADPKD).
Agraz-Pamplona I, Larrosa-Garcia M, Bury-Macias RP, Serón-Micas D, Montoro-Ronsano JB. Agraz-Pamplona I, et al. Among authors: larrosa garcia m. Eur J Clin Pharmacol. 2020 Oct;76(10):1473-1475. doi: 10.1007/s00228-020-02906-z. Epub 2020 Jun 8. Eur J Clin Pharmacol. 2020. PMID: 32514744 Free PMC article. No abstract available.
Long-term effectiveness of an intervention to enhance mirabegron use revision and its deprescribing: 36-month follow-up of a quasi-experimental trial in primary care.
Fernández-Liz E, Vivó-Tristante P, Aranzana-Martínez A, Barceló-Colomer ME, Larrosa-Garcia M, Del Val García JL, Martín-Gracia E; ; on behalf of the Urinary Incontinence Improvement Clinical Group. Fernández-Liz E, et al. Among authors: larrosa garcia m. Curr Med Res Opin. 2021 Apr;37(4):703-710. doi: 10.1080/03007995.2021.1885366. Epub 2021 Feb 26. Curr Med Res Opin. 2021. PMID: 33538192